We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Grants De Novo Clearance to Heart Disease Testing Software
FDA Grants De Novo Clearance to Heart Disease Testing Software
Medical software that allows caregivers to noninvasively evaluate blood flow in patients with coronary artery disease gained marketing clearance from the FDA late last month.